| 0.2 μM APC | CONTROL | ||||||
---|---|---|---|---|---|---|---|---|
Specimen | Metaphase cells analysed | Normal (%) | Aberrant (%) | Breaks/Metaphase | Metaphase cells analysed | Normal (%) | Aberrant (%) | Breaks/Metaphase |
OAF1 | 130 | 48 (36.92%) | 82 (63.08%) | 1.64 | 132 | 127 (96.21%) | 5 (3.78%) | 0.045 |
OAF3 | 244 | 134 (54.92%) | 110 (46.08%) | 0.59 | 146 | 140 (95.89%) | 6 (4.11%) | 0.041 |
total | 374 | 182 (48.66%) | 192 (51.34%) | 1.12 | 278 | 267 (96.04%) | 11 (3.96%) | 0.043 |
CAS1 | 134 | 33 (24.66%) | 101 (75.34%) | 1.42 | 223 | 204 (91.48%) | 19 (8.52%) | 0.10 |
CAS2 | 165 | 51 (30.91%) | 114 (69.09%) | 1.60 | 209 | 197 (94.26%) | 12 (5.74%) | 0.05 |
CAS3 | 183 | 67 (36.61%) | 116 (63.39%) | 0.95 | 133 | 124 (93.23%) | 9 (6.77%) | 0.07 |
total | 482 | 151 (31.33%) | 331 (68.67%) | 0.99 | 565 | 525 (92.92%) | 40 (7.08%) | 0.07 |
EED1 | 188 | 49 (26.06%) | 139 (73.94%) | 1.29 | 233 | 134 (90.54%) | 14 (9.46%) | 0.10 |
EED2 | 170 | 29 (17.06%) | 141 (82.94%) | 1.44 | 164 | 150 (89.82%) | 17 (10.18%) | 0.12 |
EED3 | 162 | 46 (28.40%) | 116 (71.60%) | 1.23 | 193 | 177 (91.71%) | 16 (8.29%) | 0.07 |
EED4 | 100 | 24 (24%) | 76 (76%) | 1.36 | 111 | 104 (93.69%) | 7 (6.31%) | 0.09 |
total | 620 | 148 (23.87%) | 280 (78.21%) | 1.33 | 619 | 565 (91.32%) | 54 (8.77%) | 0.09 |